LB

Lipa Begam

Active Director Director DIN 09840383
DIN 09840383 First appointment Dec 2022 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Lipa Begam

Data last updated:

Lipa Begam is a Director at Wellsun Pharmaceuticals Private Limited (since 2022). The company operates in Chemicals.

DIN 09840383
Primary Designation Director
Industry Chemicals
First Appointment 31 Dec 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director31 Dec 20222022Active

Board colleagues of Lipa Begam

NameDINCompanyDesignation
Niladri Ghosh09711067Wellsun Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Wellsun Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Lipa Begam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lipa Begam

Lipa Begam currently holds 1 directorship: Wellsun Pharmaceuticals Private Limited (Director, since 31 Dec 2022).

Lipa Begam was first appointed on 31 Dec 2022 as Director at Wellsun Pharmaceuticals Private Limited.

The current boards of Lipa Begam's companies include Niladri Ghosh (Wellsun Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available